Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
33965 | 118 | 56.8 | 94% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
227 | 3 | MICRORNA//MIRNA//GENE DELIVERY | 49432 |
57 | 2 | MICRORNA//MIRNA//LONG NONCODING RNAS | 29594 |
33965 | 1 | HSA MIR 29A 3P//PHARMACOEPIGENETICS//ABCC2 HAPLOTYPE | 118 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HSA MIR 29A 3P | authKW | 517552 | 2% | 100% | 2 |
2 | PHARMACOEPIGENETICS | authKW | 462094 | 4% | 36% | 5 |
3 | ABCC2 HAPLOTYPE | authKW | 258776 | 1% | 100% | 1 |
4 | C JUN SP1 | authKW | 258776 | 1% | 100% | 1 |
5 | DIFFERENCES IN DRUG METABOLISM | authKW | 258776 | 1% | 100% | 1 |
6 | DNA METHYLATION MAPPING | authKW | 258776 | 1% | 100% | 1 |
7 | DRUG METABOLISM AND CLEARANCE | authKW | 258776 | 1% | 100% | 1 |
8 | EPIGENETIC DRUGS AND CHEMOPREVENTIVE AGENTS | authKW | 258776 | 1% | 100% | 1 |
9 | EPIGENETICS HISTONE MODIFICATIONS | authKW | 258776 | 1% | 100% | 1 |
10 | GUANGDONG TCM METAB | address | 258776 | 1% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 1692 | 69% | 0% | 81 |
2 | Oncology | 70 | 14% | 0% | 17 |
3 | Toxicology | 63 | 8% | 0% | 9 |
4 | Genetics & Heredity | 20 | 7% | 0% | 8 |
5 | Cell Biology | 14 | 8% | 0% | 9 |
6 | Biochemistry & Molecular Biology | 14 | 14% | 0% | 16 |
7 | Medicine, Research & Experimental | 8 | 4% | 0% | 5 |
8 | Biotechnology & Applied Microbiology | 2 | 3% | 0% | 4 |
9 | Materials Science, Biomaterials | 1 | 1% | 0% | 1 |
10 | Multidisciplinary Sciences | 1 | 1% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | GUANGDONG TCM METAB | 258776 | 1% | 100% | 1 |
2 | HUNAN PHARMACOGENETXIANGYA HOSP | 258776 | 1% | 100% | 1 |
3 | INS PATHOL NEUROPATHOL | 258776 | 1% | 100% | 1 |
4 | MED AUBFM | 258776 | 1% | 100% | 1 |
5 | ORTHOGERIATR REHABIL STABILITAT | 258776 | 1% | 100% | 1 |
6 | UNITE MEDIAN CNRS | 258776 | 1% | 100% | 1 |
7 | ALFRED MED EDUC PROJECT | 129387 | 1% | 50% | 1 |
8 | CLIN PHARMACOL INNOVAT THER EUT | 129387 | 1% | 50% | 1 |
9 | INTER MOL TOXICOL PROGRAM | 129387 | 1% | 50% | 1 |
10 | MONITORING INNOVAT THER IES | 129387 | 1% | 50% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PHARMACOGENOMICS | 9346 | 7% | 0% | 8 |
2 | DRUG METABOLISM AND DISPOSITION | 6762 | 12% | 0% | 14 |
3 | BIOLOGY OF SEX DIFFERENCES | 5911 | 2% | 1% | 2 |
4 | MOLECULAR INTERVENTIONS | 2173 | 1% | 1% | 1 |
5 | CLINICAL PHARMACOLOGY & THERAPEUTICS | 1594 | 5% | 0% | 6 |
6 | DRUG METABOLISM AND PHARMACOKINETICS | 1432 | 2% | 0% | 2 |
7 | JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS | 1305 | 1% | 1% | 1 |
8 | JOURNAL OF APPLIED BIOMEDICINE | 1095 | 1% | 0% | 1 |
9 | CURRENT DRUG METABOLISM | 942 | 2% | 0% | 2 |
10 | WILEY INTERDISCIPLINARY REVIEWS-SYSTEMS BIOLOGY AND MEDICINE | 838 | 1% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | CHEN, YM , XIAO, JF , ZHANG, XL , BIAN, XW , (2016) MICRORNAS AS KEY MEDIATORS OF HEPATIC DETOXIFICATION.TOXICOLOGY. VOL. 368. ISSUE . P. 80 -90 | 25 | 25% | 0 |
2 | YU, AM , TIAN, Y , TU, MJ , HO, PY , JILEK, JL , (2016) MICRORNA PHARMACOEPIGENETICS: POSTTRANSCRIPTIONAL REGULATION MECHANISMS BEHIND VARIABLE DRUG DISPOSITION AND STRATEGY TO DEVELOP MORE EFFECTIVE THERAPY.DRUG METABOLISM AND DISPOSITION. VOL. 44. ISSUE 3. P. 308 -319 | 28 | 17% | 3 |
3 | LI, MM , WANG, WP , WU, WJ , HUANG, M , YU, AM , (2014) RAPID PRODUCTION OF NOVEL PRE-MICRORNA AGENT HSA-MIR-27B IN ESCHERICHIA COLI USING RECOMBINANT RNA TECHNOLOGY FOR FUNCTIONAL STUDIES IN MAMMALIAN CELLS.DRUG METABOLISM AND DISPOSITION. VOL. 42. ISSUE 11. P. 1791 -1795 | 14 | 38% | 5 |
4 | LI, MP , HU, YD , HU, XL , ZHANG, YJ , YANG, YL , JIANG, C , TANG, J , CHEN, XP , (2016) MIRNAS AND MIRNA POLYMORPHISMS MODIFY DRUG RESPONSE.INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. VOL. 13. ISSUE 11. P. - | 27 | 19% | 0 |
5 | YU, DAK , GREEN, B , TOLLESON, WH , JIN, YQ , MEI, N , GUO, YL , DENG, HL , POGRIBNY, I , NING, BT , (2015) MICRORNA HSA-MIR-29A-3P MODULATES CYP2C19 IN HUMAN LIVER CELLS.BIOCHEMICAL PHARMACOLOGY. VOL. 98. ISSUE 1. P. 215 -223 | 12 | 32% | 8 |
6 | MORIYA, N , KATAOKA, H , NISHIKAWA, J , KUGAWA, F , (2016) IDENTIFICATION OF CANDIDATE TARGET CYP GENES FOR MICRORNAS WHOSE EXPRESSION IS ALTERED BY PCN AND TCPOBOP, REPRESENTATIVE LIGANDS OF PXR AND CAR.BIOLOGICAL & PHARMACEUTICAL BULLETIN. VOL. 39. ISSUE 8. P. 1381 -1386 | 9 | 41% | 1 |
7 | ZHONG, XB , LEEDER, JS , (2013) EPIGENETIC REGULATION OF ADME-RELATED GENES: FOCUS ON DRUG METABOLISM AND TRANSPORT.DRUG METABOLISM AND DISPOSITION. VOL. 41. ISSUE 10. P. 1721-1724 | 12 | 32% | 8 |
8 | BOLLEYN, J , DE KOCK, J , RODRIGUES, RM , VINKEN, M , ROGIERS, V , VANHAECKE, T , (2015) MICRORNAS AS KEY REGULATORS OF XENOBIOTIC BIOTRANSFORMATION AND DRUG RESPONSE.ARCHIVES OF TOXICOLOGY. VOL. 89. ISSUE 9. P. 1523 -1541 | 17 | 20% | 4 |
9 | KIM, IW , HAN, N , BURCKART, GJ , OH, JM , (2014) EPIGENETIC CHANGES IN GENE EXPRESSION FOR DRUG-METABOLIZING ENZYMES AND TRANSPORTERS.PHARMACOTHERAPY. VOL. 34. ISSUE 2. P. 140-150 | 15 | 21% | 14 |
10 | YU, DAK , TOLLESON, WH , KNOX, B , JIN, YQ , GUO, L , GUO, YL , KADLUBAR, SA , NING, BT , (2015) MODULATION OF ALDH5A1 AND SLC22A7 BY MICRORNA HSA-MIR-29A-3P IN HUMAN LIVER CELLS.BIOCHEMICAL PHARMACOLOGY. VOL. 98. ISSUE 4. P. 671 -680 | 12 | 26% | 0 |
Classes with closest relation at Level 1 |
Rank | Class id | link |
---|---|---|
1 | 3955 | PREGNANE X RECEPTOR//PXR//CONSTITUTIVE ANDROSTANE RECEPTOR |
2 | 37472 | MIR 22//MIR 22 3P//AUTHOR OUTPATIENT |
3 | 28818 | HEPARG CELLS//HEPARG//NEOHEPATOCYTES |
4 | 8182 | MIR 122//MICRORNA 122//MICRORNA |
5 | 14933 | CYP1B1//CYP2S1//CYP2W1 |
6 | 14729 | MIR 33//MARC RUTI BELL VASC BIOL DIS PROGRAM//INTEGRAT CELL SIGNALING NEUROBIOL METAB PROGRAM |
7 | 1139 | MICRORNA//MIRNA//DROSHA |
8 | 9334 | ABCG2//BCRP//BREAST CANCER RESISTANCE PROTEIN |
9 | 88 | MICRORNA//MIR 21//MIRNA |
10 | 5907 | CYP3A5//ABCB1//MDR1 |